http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html <p align="justify">BRISBANE, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on June 13, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).</p> <p align="justify">In the aggregate, the two new non-executive employees received options to purchase 705,000 shares of Annexon common stock. The options carry a ten-year http://www.streetinsider.com/Press+Releases/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html Tue, 16 Jun 2026 16:05:00 -0400 ANNX O.12845549 http://www.streetinsider.com/Press+Releases/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html <p align="justify">BRISBANE, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on June 13, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).</p> <p align="justify">In the aggregate, the two new non-executive employees received options to purchase 705,000 shares of Annexon common stock. The options carry a ten-year http://www.streetinsider.com/Press+Releases/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html Tue, 16 Jun 2026 16:05:00 -0400 ANNX O.12845549 http://www.streetinsider.com/Globe+Newswire/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html <p align="justify">BRISBANE, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on June 13, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).</p> <p align="justify">In the aggregate, the two new non-executive employees received options to purchase 705,000 shares of Annexon common stock. The options carry a ten-year http://www.streetinsider.com/Globe+Newswire/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html Tue, 16 Jun 2026 16:05:00 -0400 ANNX O.12845549 http://www.streetinsider.com/Globe+Newswire/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html <p align="justify">BRISBANE, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on June 13, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).</p> <p align="justify">In the aggregate, the two new non-executive employees received options to purchase 705,000 shares of Annexon common stock. The options carry a ten-year http://www.streetinsider.com/Globe+Newswire/Annexon+Reports+Inducement+Grants+to+New+Employees+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26653986.html Tue, 16 Jun 2026 16:05:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Carson+William+H./26647542.html si-local-file:///var/storage/secattach/20260615/26647542.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Carson+William+H./26647542.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Carson+William+H./26647542.html si-local-file:///var/storage/secattach/20260615/26647542.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Carson+William+H./26647542.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Yednock+Ted/26647547.html si-local-file:///var/storage/secattach/20260615/26647547.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Yednock+Ted/26647547.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Yednock+Ted/26647547.html si-local-file:///var/storage/secattach/20260615/26647547.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Yednock+Ted/26647547.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Choi+Jung/26647550.html si-local-file:///var/storage/secattach/20260615/26647550.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Choi+Jung/26647550.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Choi+Jung/26647550.html si-local-file:///var/storage/secattach/20260615/26647550.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Choi+Jung/26647550.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Cockroft+Bettina+M./26647552.html si-local-file:///var/storage/secattach/20260615/26647552.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Cockroft+Bettina+M./26647552.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Cockroft+Bettina+M./26647552.html si-local-file:///var/storage/secattach/20260615/26647552.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Cockroft+Bettina+M./26647552.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Satter+Muneer+A/26647557.html si-local-file:///var/storage/secattach/20260615/26647557.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Satter+Muneer+A/26647557.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Satter+Muneer+A/26647557.html si-local-file:///var/storage/secattach/20260615/26647557.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Satter+Muneer+A/26647557.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+JONES+WILLIAM+A+JR/26647558.html si-local-file:///var/storage/secattach/20260615/26647558.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+JONES+WILLIAM+A+JR/26647558.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+JONES+WILLIAM+A+JR/26647558.html si-local-file:///var/storage/secattach/20260615/26647558.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+JONES+WILLIAM+A+JR/26647558.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Waddill+William+D./26647566.html si-local-file:///var/storage/secattach/20260615/26647566.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Waddill+William+D./26647566.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Waddill+William+D./26647566.html si-local-file:///var/storage/secattach/20260615/26647566.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11++Filed+by%3A+Waddill+William+D./26647566.html Mon, 15 Jun 2026 16:15:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11/26641014.html si-local-file:///var/storage/secattach/20260612/26641014.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11/26641014.html Fri, 12 Jun 2026 16:16:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11/26641014.html si-local-file:///var/storage/secattach/20260612/26641014.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Annexon%2C+Inc.+++++++++++++For%3A+Jun+11/26641014.html Fri, 12 Jun 2026 16:16:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+May+28++Filed+by%3A+Satter+Muneer+A/26576626.html si-local-file:///var/storage/secattach/20260529/26576626.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+May+28++Filed+by%3A+Satter+Muneer+A/26576626.html Fri, 29 May 2026 17:21:00 -0400 ANNX O.12845549 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+May+28++Filed+by%3A+Satter+Muneer+A/26576626.html si-local-file:///var/storage/secattach/20260529/26576626.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Annexon%2C+Inc.+++++++++++++For%3A+May+28++Filed+by%3A+Satter+Muneer+A/26576626.html Fri, 29 May 2026 17:21:00 -0400 ANNX O.12845549 http://www.streetinsider.com/Press+Releases/Annexon+to+Participate+in+Upcoming+June+Investor+Conferences/26553773.html <p align="left">BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=QSIXGrJbOI0lyikBTqWQ_ZY3DNd31fXCxC-uMxfa4hJoVBTmqq4UNbPF2hMCrnVE0m_4gWhn-sD5tJ3HHADz1S4PAsB9d-0GAL39oDeqFhbbpzzMjMJZkTjacF1FZrNHbnqGs2WEg6xsF49hc7FFlubXWayBntGQy-B_QXZSryEWVMusDFsFz0BeTD0CPfTY8RsD1Iqajqmnba07Y2A4MzczxQAuK3rPJwgEAx1dd6k=" rel="nofollow" target="_blank">Annexon, Inc.</a> (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;">Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and, <br/><br/></li><li style="margin-bottom:8pt;">Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET http://www.streetinsider.com/Press+Releases/Annexon+to+Participate+in+Upcoming+June+Investor+Conferences/26553773.html Wed, 27 May 2026 08:00:00 -0400 A.50216777 ANNX O.12845549 O.54516537 http://www.streetinsider.com/Press+Releases/Annexon+to+Participate+in+Upcoming+June+Investor+Conferences/26553773.html <p align="left">BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=QSIXGrJbOI0lyikBTqWQ_ZY3DNd31fXCxC-uMxfa4hJoVBTmqq4UNbPF2hMCrnVE0m_4gWhn-sD5tJ3HHADz1S4PAsB9d-0GAL39oDeqFhbbpzzMjMJZkTjacF1FZrNHbnqGs2WEg6xsF49hc7FFlubXWayBntGQy-B_QXZSryEWVMusDFsFz0BeTD0CPfTY8RsD1Iqajqmnba07Y2A4MzczxQAuK3rPJwgEAx1dd6k=" rel="nofollow" target="_blank">Annexon, Inc.</a> (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;">Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and, <br/><br/></li><li style="margin-bottom:8pt;">Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET http://www.streetinsider.com/Press+Releases/Annexon+to+Participate+in+Upcoming+June+Investor+Conferences/26553773.html Wed, 27 May 2026 08:00:00 -0400 A.50216777 ANNX O.12845549 O.54516537 http://www.streetinsider.com/Press+Releases/Annexon+to+Participate+in+Upcoming+June+Investor+Conferences/26553773.html <p align="left">BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=QSIXGrJbOI0lyikBTqWQ_ZY3DNd31fXCxC-uMxfa4hJoVBTmqq4UNbPF2hMCrnVE0m_4gWhn-sD5tJ3HHADz1S4PAsB9d-0GAL39oDeqFhbbpzzMjMJZkTjacF1FZrNHbnqGs2WEg6xsF49hc7FFlubXWayBntGQy-B_QXZSryEWVMusDFsFz0BeTD0CPfTY8RsD1Iqajqmnba07Y2A4MzczxQAuK3rPJwgEAx1dd6k=" rel="nofollow" target="_blank">Annexon, Inc.</a> (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president &amp; chief executive officer, will participate in fireside chats during the following June investor conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;">Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET in New York, NY; and, <br/><br/></li><li style="margin-bottom:8pt;">Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 8:00 a.m. ET http://www.streetinsider.com/Press+Releases/Annexon+to+Participate+in+Upcoming+June+Investor+Conferences/26553773.html Wed, 27 May 2026 08:00:00 -0400 A.50216777 ANNX O.12845549 O.54516537